Page last updated: 2024-08-16

salmeterol xinafoate and Chronic Bronchitis

salmeterol xinafoate has been researched along with Chronic Bronchitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almond, MA; Bennett, WD; Donohue, JF; Johnson, JG; Zeman, KL1
Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P1

Trials

1 trial(s) available for salmeterol xinafoate and Chronic Bronchitis

ArticleYear
Effect of salmeterol on mucociliary and cough clearance in chronic bronchitis.
    Pulmonary pharmacology & therapeutics, 2006, Volume: 19, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Bronchitis, Chronic; Cough; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Mucociliary Clearance; Salmeterol Xinafoate

2006

Other Studies

1 other study(ies) available for salmeterol xinafoate and Chronic Bronchitis

ArticleYear
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
    Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142

    Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload

2008